2 Patents
- US122820142025Methods of Identifying Compounds That Interfere with Erg-driven Misguidance of BAF Complexes in TMPRSS2-ERG Driven Prostate Cancers
Dana-farber Cancer Institute, Inc.
0 cites - US121092122024Methods of Treating Cancer Having an Active Wnt/β-catenin Pathway
DANA-FARBER CANCER INSTITUTE, Inc.
0 cites